In early January 2026, UBS upgraded Bristol-Myers Squibb after highlighting its broad drug pipeline, new clinical trial ...
JNJ cuts U.S. drug prices under a Trump deal, gains a tariff reprieve, and accelerates a $55 billion push to expand domestic manufacturing.
In a release, the Ministry of Railways said that while the plan is to double the capacity by 2030, it is expected to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results